Anbio Biotechnology (NNNN) Cash & Current Investments (2023 - 2025)

Anbio Biotechnology's Cash & Current Investments history runs 3 years deep, the most recent figure standing at $11.9 million for Q4 2025.

• In Q4 2025, Cash & Current Investments rose 1.19% year-over-year to $11.9 million; the TTM figure through Dec 2025 stood at $11.9 million (up 1.19% YoY), while the FY2025 annual figure was $11.9 million, up 1.19% from the prior year.
• Cash & Current Investments was $11.9 million for Q4 2025 at Anbio Biotechnology, down from $13429.0 billion in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $13429.0 billion in Q2 2025 to a low of $9.7 million in Q4 2023.
• Historically, Cash & Current Investments has averaged $3357.3 billion across 3 years, with a median of $11.8 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments advanced 21.36% in 2024, then climbed 1.19% in 2025.
• A 3-year view of Cash & Current Investments shows it stood at $9.7 million in 2023, then gained by 21.36% to $11.8 million in 2024, then climbed by 1.19% to $11.9 million in 2025.
• The last three Cash & Current Investments figures came in at $11.9 million (Q4 2025), $13429.0 billion (Q2 2025), and $11.8 million (Q4 2024), per Business Quant data.